SB 858
Relating to controlled substance schedules and to clean-up errors identified in code sections
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Senate
- Passed House of Delegates
- To Governor
- Became Law
Bill overview
Senate Bill 858 aims to correct errors and inconsistencies in West Virginia’s controlled substance schedules outlined in the state code. Specifically, it updates the list of drugs included in Schedules I, II, III, and V, adding several new substances and clarifying existing classifications. The bill addresses synthetic cannabinoids, depressants, stimulants, and other controlled substances, ensuring accurate scheduling for public safety and regulatory compliance.
Key provisions
- Updates the list of drugs in Schedule I, including fentanyl analogs, various opioids, stimulants, and depressants.
- Adds several synthetic cannabinoids to Schedule I, reflecting evolving drug trends.
- Clarifies the scheduling of certain depressants, such as gabapentin and pregabalin.
- Includes a provision to address immediate precursors to controlled substances.
- Updates the list of substances in Schedule II, including specific fentanyl derivatives.
- Revises the definitions and quantities for controlled substances in Schedules III and IV.
- Addresses the scheduling of certain compounds, such as Brivaracetam and Lasmiditan.
- Specifies that certain substances, like dronabinol, are exempt from scheduling under specific conditions.
Who is affected
- Healthcare professionals (prescribers, pharmacists)
- Law enforcement agencies
- Drug manufacturers and distributors
- Patients and individuals seeking controlled substances
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yours